ProPhase Labs Reports First Quarter 2021 Financial Results and Announces $0.30 Special Cash Dividend
May 13, 2021 16:05 ET
|
ProPhase Labs, Inc.
First Quarter 2021 Revenue Increases 709% to $15.3 Million Driven by New Diagnostic Services Business Gross Profit Increases to $8.9 Million With Net Income of $1.1 Million or $0.07 Per Share ...
Corbus Pharmaceuticals Reports Last Subject Visit in DETERMINE Phase 3 Study of Lenabasum for Treatment of Dermatomyositis
March 30, 2021 08:05 ET
|
Corbus Pharmaceuticals Holdings, Inc.
Topline data on schedule for Q2 2021Dermatomyositis is a rare and life-threatening autoimmune disease characterized by skin and muscle inflammation, and affects ~80,000 people in North America, EU,...
QSAM Biosciences Closes Series B Preferred Private Placement; $2.5 Million in New Capital to Fund Upcoming Clinical Trials
January 28, 2021 09:00 ET
|
QSAM Biosciences Inc.
Austin, Texas, Jan. 28, 2021 (GLOBE NEWSWIRE) -- QSAM Biosciences Inc. (OTCQB: QSAM), a company developing next-generation nuclear medicines for the treatment of cancer and related diseases,...
Lem Moyé launches a new press campaign for his 2017 novel ‘Saving Grace’
September 23, 2020 00:00 ET
|
Trafford Publishing
CHANDLER, Ariz., Sept. 23, 2020 (GLOBE NEWSWIRE) -- A controversial viral infection offered as revolutionary therapy; a struggling family damaged in the name of science; a deadly disease rising from...
FDA ‘Black Box’ Lacks Transparency, Writes Editor of the Journal of American Physicians and Surgeons
June 22, 2020 10:41 ET
|
Association of American Physicians and Surgeons
TUCSON, Ariz., June 22, 2020 (GLOBE NEWSWIRE) -- The Food and Drug Administration (FDA), the oldest “consumer protection agency” in our federal government, has lacked transparency for many years,...
Weigh Risks and Benefits of COVID-19 Response, Advises Association of American Physicians and Surgeons (AAPS)
March 21, 2020 13:16 ET
|
Association of American Physicians and Surgeons
TUCSON, Ariz., March 21, 2020 (GLOBE NEWSWIRE) -- A new group called US Healthcare Providers for Federal Action Against COVID-19 has launched a petition on change.org calling for an immediate...
PAVmed Provides Update on CarpX™ Clinical Safety Study
December 13, 2019 09:30 ET
|
PAVmed Inc.
NEW YORK, Dec. 13, 2019 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multiproduct medical device company, today provided an update on...
Biofrontera receives FDA approval for upscaling of batch size for Ameluz® production
January 08, 2019 02:02 ET
|
Biofrontera AG
Leverkusen, Germany, Jan. 08, 2019 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today announced that...
Corbus Pharmaceuticals Initiates “DETERMINE” Phase 3 Study in Dermatomyositis
December 17, 2018 07:00 ET
|
Corbus Pharmaceuticals Holdings, Inc.
DM is a rare systemic autoimmune disease that affects ~80,000 individuals in the U.S., EU and Japan and has a 5-year mortality rate as high as 30% This marks Company’s second Phase 3 program in rare...
PAVmed Provides Business Update
October 17, 2018 07:30 ET
|
PAVmed Inc.
NEW YORK, Oct. 17, 2018 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multiproduct medical device company, today provided an update on...